SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED) December 18, 2002
NORTHWEST BIOTHERAPEUTICS, INC.
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
| | | | | |
DELAWARE
(STATE OR OTHER JURISDICTION
OF INCORPORATION) | | 0-33393
(COMMISSION FILE
NUMBER) | | 94-3306718
(I.R.S. EMPLOYER
IDENTIFICATION NO.) |
| | | |
21720 23rd Drive SE, Suite 100, Bothell, WA
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) | | 98021
(ZIP CODE) |
(425) 608-3000
REGISTRANT’S TELEPHONE NUMBER, INCLUDING AREA CODE
INAPPLICABLE
(FORMER NAME OR FORMER ADDRESS IF CHANGED SINCE LAST REPORT)
TABLE OF CONTENTS
ITEM 5.OTHER EVENTS
On December 18, 2002 the Company issued a press release announcing the delisting of the Company’s common stock from the Nasdaq National Market and the resignation of C. William Schneider from the Company’s Board of Directors.
ITEM 7.FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS
(c) EXHIBITS
99.1 Press Release dated December 18, 2002.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | |
| | | NORTHWEST BIOTHERAPEUTICS, INC. |
| | | | | |
| | | By: | | /S/ Daniel O. Wilds |
| | | | |
|
| | | | | Daniel O. Wilds
Chairman, President and Chief Executive Officer |
| Dated: December 19, 2002 | | | | |
EXHIBIT INDEX
| | | | | | | |
| EXHIBIT | | | | | | |
| NUMBER | | DESCRIPTION | | | | |
| |
| | | | |
| 99.1 | | Press Release dated December 18, 2002. |
